Navigation Links
Carnegie Mellon scientists create PNA molecule with potential to build nanodevices

No matter how healthy a life one leads, no person has managed to live much longer than a century. Even though the advances of the modern age may have extended the average human life span, it is clear there are genetic limits to longevity. One prominent theory of aging lays the blame on the accumulation of damage done to DNA and proteins by “free radicals,?highly reactive molecules produced by the metabolic activity of mitochondria.

This damage is expected to reduce gene expression by damaging the DNA in which genes are encoded, and so the theory predicts that the most metabolically active tissues should show the greatest age-related reduction in gene expression. In this issue, Michael Eisen and colleagues show that the human brain follows this pattern. A similar pattern—which, surprisingly, involves different genes—is found in the brain of the aging chimpanzee.

The authors compared results from three separate studies of age-related gene expression, each done on the same type of DNA microarray and each comparing brain regions in young versus old adult humans. In four different regions of the cortex (the brain region responsible for higher functions such as thinking), they found a similar pattern of age-related change, characterized by changes in expression of hundreds of genes. In contrast, expression in one non-cortical region, the cerebellum (whose principal functions include movement), was largely unchanged with age. In addition to confirming a prediction of the free-radical theory of aging (namely, that the more metabolically active cortex should have a greater reduction in gene activity), this is the first demonstration that age-related gene expression patterns can differ in different cells of a single organism.

The authors found a similar difference in age-related patterns in the brain of the chimpanzee, with many genes down-regulated in the cortex that remained unchanged in the cerebellum. However, the set of affected cortical genes was
'"/>

Source:


Page: 1 2

Related biology news :

1. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
2. Robot-based system developed at Carnegie Mellon detects life in Chiles Atacama desert
3. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
4. Carnegie Mellon University research reveals how cells process large genes
5. Carnegie Mellon cyLab researchers work to develop new red tide monitoring
6. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
7. Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool
8. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level
9. Carnegie Mellon scientists show brain uses optimal code for sound
10. DNA conclusive yet still controversial, Carnegie Mellon professor says
11. Teens unaware of sexually transmitted diseases until they catch one, Carnegie Mellon study finds

Post Your Comments:
(Date:11/23/2009)...of General Medical Sciences (NIGMS), part of the N...42.3 million for grants in scientific areas it ide...ed the GO grant program to stimulate biomedical re... American Recovery and Reinvestment Act (Recovery ...e to have a significant impact on a field of biome...
(Date:11/23/2009)...aled how environmental irritants such as air pollu... research published today in the American Journal...uthors of the study, from Imperial College London ...action inside the lungs that can trigger coughing ...n the air. They suggest that their findings may ul...
(Date:11/23/2009)...asty business, posing dangers to human health and ...s launching a new project with funding from the U....ets the fat and grease that contribute to millions...ners new tools to further reduce the risk of sewag...y" sewer systems, as opposed to "combined" systems...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research reveals exactly how coughing is triggered by environmental irritants 2Lose the fat: Targeting grease to curtail sewer overflows 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 1Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 3Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 4Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 5Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 6Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 7CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 1CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 2Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 1Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 2
...n human stem cell research, producing embryonic-li...ly speed up the development of treatments for life... The discovery made during a project undertaken wi...anch and the Synthecon Corporation in the United S...with an ethical and reliable source of human stem ...
...e US could soon be asked to approve a human trial ...brid of the HIV and Ebola viruses. Tests on monkey...s far more efficiently than any other method devel...iller viruses sounds horrifying, the risks should ...to develop an effective form of gene therapy to tr...
...sed on a recently published article in Environment...teria and a newly discovered group of marine worms...h uses sunken marine mammals as its sole source of...tal Microbiology, Dr Shana Goffredi and her collea...ia and the Osedax (bone-devouring) group of marine...
Other Biology News:Researchers propose measures to curb lion attacks in Tanzania 2Can two killers make a cure? 2
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...eutics,Inc. (Nasdaq: FOLD ), a biopharmaceutical ...red pharmacological chaperones for the treatment o... results from its recently,completed Phase 2 clini...),for Fabry disease. As of November 2007, Amigal i...Genetic Therapies (HGT), a business unit of,Shire ...
...lved; Remaining Issues Pertain to cGMP Com...mpany Expects to Resolve cGMP Issues in the Next S...,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today anno... from the U.S. Food and Drug Administration (FDA) ...uring and controls (CMC) NDA,supplement submitted ...
... Inc. enters into an exclusive, distribution agree...d New Zealand -, LA...Technologies &,Bioressources Inc. ("Neptune") (NAS...it has entered into an exclusive distribution agre...ional") for Australia and New,Zealand. AZPA Intern...
Other Biology Technology:Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 2Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 3Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 4Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 5Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 6Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 2Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 3Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 4Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 2Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 3
...loped the Easy-Titer Human IgM Assay Kit to addres...rform assay for Human IgM that eliminates the need...and-read assay that allows the accurate determinat...oximately 30 minutes. The Pierce Easy-Titer Human ...
...ilizer is an aqueous solution that contains a puri...g chemicals in a saline solution, pH 6.5 7.5, and...ne and 0.02% bromonitrodioxane as a preservative. ...bilizer for biologically active components in solu...
Cleanascite HC 16000 from Biotech Support Group
...e Stabilizer is a bovine protein-free alternative ...ueous solution that contains non-toxic chemicals i... - 7.2, and does not contain a preservative. This...other biomolecules that are absorbed or immobilize...
Biology Products: